Hôpital Robert Debré

corporate_fareorganization

Hôpital Robert Debré

- Funding / Projects
  (34)

34 Projects, page 1 of 7

Impact of pharmacogenetic biomarkers on hepatic veno-occlusive disease occurrence during treatment by hematopoietic stem cell transplantation for pediatric cancers.
assignment_turned_inProjectPartners:Hôpital Saint-Louis, Hôpital Robert Debré
Hôpital Saint-Louis,
Hôpital Robert Debré
Funder: Institut National du Cancer Project Code: INCa-DGOS-11152
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Validation of the impact of genetic aberrations and host genetic variation in childhood acute lymphoblastic leukemia for integration into clinical practice
assignment_turned_inProject2013 - 2016Partners:Hôpital Robert Debré
Hôpital Robert Debré
Funder: Institut National du Cancer Project Code: INCa-6507
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Role and interactions between immunoregulatory T lymphocytes subtypes after allogeneic haematopoïetic stem cell transplantation (HSCT): identification of new partners implicated on the development of GVT (graft versus tumor) and anti-infectious responses without GVHD (graft versus host disease).
assignment_turned_inProject2012 - 2015Partners:Hôpital Saint-Antoine, Groupe Hospitalier Pitié Salpétrière, Hôpital Necker- Enfants malades, Institut Curie, UNIVERSITE RENE DESCARTES PARIS 5 +2 partners
Hôpital Saint-Antoine,
Groupe Hospitalier Pitié Salpétrière,
Hôpital Necker- Enfants malades,
Institut Curie,
UNIVERSITE RENE DESCARTES PARIS 5,
Hôpital Saint-Louis,
Hôpital Robert Debré
Funder: Institut National du Cancer Project Code: INCa-5742
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Randomized phase III study comparing preoperative chemoradiotherapy alone versus neoadjuvant chemotherapy with Folfirinox regimen followed by preoperative chemoradiotherapy for patients with resectable locally advanced rectal cancer. A PRODIGE –GERCOR-SFRO-GRECCAR study.
assignment_turned_inProjectPartners:Polyclinique du Bois, Hôpital Robert Debré, Institut Gustave Roussy, Hôpital Jean Minjoz, Centre Antoine Lacassagne +22 partners
Polyclinique du Bois,
Hôpital Robert Debré,
Institut Gustave Roussy,
Hôpital Jean Minjoz,
Centre Antoine Lacassagne,
Centre hospitalier de Boulogne-sur-Mer,
CHU,
Centre Hospitalier de Colmar,
Centre Paul Strauss,
CHU Marseille - Hôpital la Timone,
Institut Mutualiste Montsouris,
Hôpital le Bocage,
Institut Bergonié,
Centre hospitalier de Blois,
Hôpital Saint-Louis,
Centre Hospitalier Départemental de Vendée - La Roche-sur-Yon,
Centre Eugène Marquis,
Clinique armoricaine de radiologie,
Hôpital Saint André,
Centre René Gauducheau,
Hôpital Saint-Antoine,
Hôpital de La Source,
Centre Oscar Lambret,
Groupe Hospitalier Pitié Salpétrière,
Institut de Cancérologie de Lorraine,
SCM de Radiothérapie - Centre Maurice Tubiana,
PBNA
Funder: Institut National du Cancer Project Code: INCa-DGOS-3687
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Phase II/III randomised multicentre trial using a factorial design evaluating the advantage (i) of a strategy of primary surgery vs primary chemotherapy and (ii) chemotherapy with XELOX vs ECF in resectable gastric signet ring cell adenocarcinomas.
assignment_turned_inProjectPartners:HCL, Hôpital de la Croix-Rousse, Hôpital Beaujon, Hôpital Saint-Antoine, Hôpital Purpan +25 partners
HCL,
Hôpital de la Croix-Rousse,
Hôpital Beaujon,
Hôpital Saint-Antoine,
Hôpital Purpan,
Université de Lille III (Charles-de-Gaulle),
Groupe Hospitalier Henri Mondor - Albert Chenevier,
Hôpital Louis Mourier,
CHU Marseille - Hôpital la Timone,
Centre Hospitalier Universitaire de Nîmes,
Hôpital Tenon,
Centre Hospitalier Universitaire de Rennes,
HUS,
Hôpital Trousseau,
Hôpital Édouard Herriot,
Centre Hospitalier Universitaire d'Angers,
Hôpital Avicenne,
Centre Georges-François Leclerc,
Centre Léon Bérard,
Hôpital Ambroise Paré,
Institut Paoli-Calmettes- (IPC),
Institut Gustave Roussy,
Hôpital Européen Georges Pompidou (HEGP) - AP-,
Hôpital le Bocage,
Hôpital Claude Huriez,
Hôpital Charles-Nicolle,
Groupe Hospitalier Lariboisière - Fernand Widal,
Hôpital Hôtel-Dieu,
Hôpital Robert Debré,
Hôpital Haut-Lévêque
Funder: Institut National du Cancer Project Code: INCa-DGOS-3768
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
3
4
5
chevron_right

Hôpital Robert Debré

Hôpital Robert Debré

34 Projects, page 1 of 7

Impact of pharmacogenetic biomarkers on hepatic veno-occlusive disease occurrence during treatment by hematopoietic stem cell transplantation for pediatric cancers.

Validation of the impact of genetic aberrations and host genetic variation in childhood acute lymphoblastic leukemia for integration into clinical practice

Role and interactions between immunoregulatory T lymphocytes subtypes after allogeneic haematopoïetic stem cell transplantation (HSCT): identification of new partners implicated on the development of GVT (graft versus tumor) and anti-infectious responses without GVHD (graft versus host disease).

Randomized phase III study comparing preoperative chemoradiotherapy alone versus neoadjuvant chemotherapy with Folfirinox regimen followed by preoperative chemoradiotherapy for patients with resectable locally advanced rectal cancer. A PRODIGE –GERCOR-SFRO-GRECCAR study.

Phase II/III randomised multicentre trial using a factorial design evaluating the advantage (i) of a strategy of primary surgery vs primary chemotherapy and (ii) chemotherapy with XELOX vs ECF in resectable gastric signet ring cell adenocarcinomas.

Loading